Talc and silver nitrate induce systemic inflammatory effects during the acute phase of experimental pleurodesis in rabbits

Chest

Volumn 125, Issue 6, 2004, Pages 2268-2277

  Marchi, Evaldo ^a   Vargas, Francisco S ^a   Acencio, Milena M P ^a   Antonangelo, Leila ^a   Teixeira, Lisete R ^a   Genofre, Eduardo H ^a   Light, Richard W ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SAINT THOMAS HOSPITAL   (United States)

Author keywords

Inflammation; Interleukin 8; Pleura; Pleurodesis; Silver nitrate; Talc; Vascular endothelial growth factor

Indexed keywords

INTERLEUKIN 8; LACTATE DEHYDROGENASE; SILVER NITRATE; TALC; VASCULOTROPIN;

ACUTE PHASE RESPONSE; ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; INFLAMMATION; LACTATE DEHYDROGENASE BLOOD LEVEL; LEUKOCYTE COUNT; LUNG; MALE; NEUTROPHIL; NONHUMAN; PLEURA FLUID; PLEURODESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RABBIT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 2942753820     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.125.6.2268     Document Type: Article

References (41)

1. Walker-Renard PB, Vaughan LM, Sahn SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 1994; 120:56-64
2. Light RW. Pleural diseases. 4th ed. Philadelphia, PA: Lippincott Williams & Wilkins, 2001
3. Agrenius V, Chmielewska J, Widström O, et al. Increased coagulation activity of the pleura after tube drainage and quinacrine instillation in malignant pleural effusion. Eur Respir J 1991; 4:1135-1139
4. Koldsland S, Svennevig JL, Lehne G, et al. Chemical pleurodesis in malignant pleural effusions: a randomized prospective study of mepacrine versus bleomycin. Thorax 1993; 48:790-793
5. Wallach HW. Intrapleural tetracycline for malignant pleural effusions. Chest 1975; 68:510-512
6. Gravelyn TR, Michelson MK, Gross BH, et al. Tetracycline pleurodesis for malignant pleural effusions. Cancer 1987; 59:1973-1977
7. Landvater L, Hix WR, Mills M, et al. Malignant pleural effusion treated by tetracycline therapy. Chest 1988; 93: 1196-1198
8. Light RW, O'Hare VS, Moritz TE, et al. Intrapleural tetracycline for the prevention of recurrent spontaneous pneumothorax: results of a Department of Veterans Affairs cooperative study. JAMA 1990; 264:2224-2230
9. Kitamura S, Sugiyama Y, Izumi T, et al. Intrapleural doxycycline for control of malignant pleural effusion. Curr Ther Res Clin Exp 1981; 30:515-521
10. Muir JF, Deffouilloy C, Ndarurunze S, et al. The use of intrapleural doxycycline by lavage: drainage in recurrent effusions of neoplastic origin. Rev Mal Respir 1987; 4:29-33
11. Mansson T. Treatment of malignant pleural effusion with doxycycline. Scand J Infect Dis 1988; 53:29-34
12. Palladine W, Cunningham TJ, Sponzo R, et al. Intracavitary bleomycin in the management of malignant effusions. Cancer 1976; 38:1903-1908
13. Bitran JD, Brown C, Desser RK, et al. Intracavitary bleomycin for the control of malignant effusions. J Surg Oncol 1981; 16:273-276
14. Ostrowski MJ. An assessment of long-term results of controlling the reaccumulation of malignant effusions using intracavitary bleomycin. Cancer 1986; 57:721-727
15. Ruckdeschel JC, Moores D, Lee J, et al. Intrapleural therapy for malignant pleural effusions: a randomized comparison of bleomycin and tetracycline. Chest 1991; 100:1528-1535
16. Kessinger A, Wington RS. Intracavitary bleomycin and tetracycline in the management of malignant pleural effusions: a randomized study. J Surg Oncol 1987; 36:81-83
17. Vargas FS, Wang NS, Lee HM, et al. Effectiveness of bleomycin in comparison to tetracycline as pleural sclerosing agent in rabbits. Chest 1993; 104:1582-1584
18. Hillerdal G, Kiviloog J, Nöu E, et al. Corynebacterium parvum in malignant effusion: a randomized prospective study. Eur J Respir Dis 1986; 69:204-206
19. Rossi GA, Felletti R, Balbi B, et al. Symptomatic treatment of recurrent malignant pleural effusions with intrapleurally administered Corynebacterium parvum. Arn Rev Respir Dis 1987; 135:885-890
20. Haupt GJ, Camishion RC, Templeton JY III. Treatment of malignant pleural effusion by talc poudrage. JAMA 1960; 172:918-921
21. Weissberg D, Ben-Zeev I. Talc pleurodesis: experience with 360 patients. J Thorac Cardiovasc Surg 1993; 106:689-695
22. Kennedy L, Rusch VW, Strange C, et al. Pleurodesis using talc slurry. Chest 1994; 106:342-346
23. Viallat JR, Rey F, Astoul P, et al. Thoracoscopic talc poudrage pleurodesis for malignant pleural effusions: a review of 360 cases. Chest 1997; 110:1387-1393
24. de Campos JR, Vargas FS, Werebe EC, et al. Thoracoscopy talc poudrage: a 15-year experience. Chest 2001; 119:801-806
25. Rehse DH, Aye RW, Florence MG. Respiratory failure after talc pleurodesis. Am J Surg 1999; 177:437-440
26. Werebe EC, Pazetti R, Campos JRM, et al. Systemic distribution of talc after intrapleural administration in rats. Chest 1999; 115:190-193
27. Ferrer J, Montes JF, Villarino MA, et al. Influence of particle size on extrapleural talc dissemination after talc slurry pleurodesis. Chest 2002; 122:1018-1027
28. Brock RC. Recurrent and chronic spontaneous pneumothorax. Thorax 1948; 3:88-92
29. Andersen I, Poulsen T. Surgical treatment of spontaneous pneumothorax. Acta Chir Scand 1959; 118:105-112
30. Wied U, Halkier E, Hoeier-Madsen K, et al. Tetracycline versus silver nitrate pleurodesis in spontaneous pneumothorax. Thorac Cardiovasc Surg 1983; 86:591-593
31. Vargas FS, Teixeira LR, Silva LMMF, et al. Comparison of silver nitrate and tetracycline as a pleural sclerosing agents in rabbits. Chest 1995; 108:1080-1083
32. Vargas FS, Teixeira LR, Vaz MAC, et al. Silver nitrate is superior to talc slurry in producing pleurodesis in rabbits. Chest 2000; 118:808-813
33. Vargas FS, Teixeira LR, Antonangelo L, et al. Experimental pleurodesis in rabbits induced by silver nitrate and talc: 1-year follow-up. Chest 2001; 119:1516-1520
34. Lee YC. Cytokines in pleural diseases. In: Light RW, Lee YC, eds. Textbook of pleural diseases. London, UK: Arnold Publishers, 2003; 63-89
35. Mitchem RE, Herndon BL, Fiorella RM, et al. Pleurodesis by autologous blood, doxycycline, and talc in a rabbit model. Ann Thorac Surg 1999; 67:917-921
36. Maskell NA, Gleeson FV, Jones E, et al. Talc but not tetracycline pleurodesis induces hypoxemia and increased DTPA clearance from the contra-lateral lung [abstract]. Am J Respir Crit Care Med 2002; 165:b11
37. Campos JR, Werebe EC, Vargas FS, et al. Respiratory failure due to insufflated talc. Lancet 1997; 349:251-252
38. Fraticelli A, Robaglia-Schlupp A, Riera H, et al. Distribution of calibrated talc after intrapleural administration: an experimental study in rats. Chest 2002; 122:1737-1741
39. Sanches C, Marchi E, Romero B, et al. Association of the size of talc particles with the occurrence of complications of pleurodesis. Eur Respir J 2001; 18:515S-16S
40. Ferrer J, Villarino MA, Tura JM, et al. Talc preparations used for pleurodesis vary markedly from one preparation to another. Chest 2001; 119:1901-1905
41. Paschoalini MS, Pereira JR, Abdo EF, et al. Silver nitrate versus talc slurry for pleurodesis in patients with malignant pleural effusions [abstract]. Am J Respir Crit Care Med 1999; 159:A384